Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents-Reference-Cited by-同舟云学术

Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents

Published:2010-04 Issue:3 Volume:19 Page:195-197
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Mazurkiewicz-Bełdzińska Maria,Szmuda Marta,Matheisel Agnieszka

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference17 articles.

1. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies;Nicolson;J Neurol Neurosurg Psychiatry,2004

2. Evidence-based treatment of idiopathic generalized epilepsies with new anti-epileptic drugs;Bergey;Epilepsia,2005

3. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial;Marson;Lancet,2007

4. Valproic acid-associated weight gain in older children and teens with epilepsy;Wirrell;Pediatr Neurol,2003

5. Pregnancy outcome after in utero exposure to valproate: evidence of dose relationship in teratogenic effect;Diav-Citrin;CNS Drugs,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience with Low-Dose Sodium Valproate in Idiopathic Generalized Epilepsy Patients: A Long-Term Follow-Up Study on Selective Cohort from North India;Journal of Neurosciences in Rural Practice;2021-01

2. Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience—a European perspective;Journal of Neurology;2020-04-01

3. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial;Epilepsy Research;2019-11

4. Peripapillary retinal nerve fibre layer thinning in genetic generalized epilepsy;Seizure;2019-10

5. Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus;Epilepsia;2018-06-25